CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities
Net income	$ 201,642	$ 232,758	$ 214,840
Reconciliation of net income to net cash provided by operating activities:
Depreciation and amortization	63,914	60,438	65,045
Deferred financing cost amortization	1,081	1,120	4,514
Stock-based compensation	24,493	22,888	18,105
Provision for expected credit losses	1,211	370	2,622
Inventory obsolescence	3,163	3,841	5,337
Gain on disposal of assets	(2,985)	(1,013)	(3,156)
Deferred income taxes	35,142	19,773	17,343
Change in fair value of earn-out liability	0	16,318	14,850
(Gain) loss from revaluation of liability related to tax receivable agreement	794	(3,204)	(4,490)
Changes in operating assets and liabilities:
Accounts receivable	26,443	13,048	(11,858)
Inventories	(52,456)	(25,628)	41,922
Prepaid expenses and other assets	(5,955)	(2,267)	753
Accounts payable	(2,132)	675	8,710
Accrued expenses and other liabilities	(15,869)	28,964	(7,367)
Payments pursuant to tax receivable agreement	(20,069)	(20,800)	(26,890)
Payment of earn-out liability	0	(31,168)	0
Net cash provided by operating activities	258,417	316,113	340,280
Cash flows from investing activities
Acquisition of a business, net of cash and cash equivalents acquired	0	0	(616,189)
Investment in unconsolidated affiliates	(6,000)	0	0
Capital expenditures and other	(38,805)	(39,176)	(43,977)
Proceeds from sale of assets	5,742	3,788	5,373
Net cash used in investing activities	(39,063)	(35,388)	(654,793)
Cash flows from financing activities
Proceeds from the issuance of long-term debt	0	0	155,000
Repayments of borrowings of long-term debt	0	0	(155,000)
Payment of contingent consideration	0	(5,960)	0
Net proceeds from the issuance of Class A common stock	0	0	169,878
Payments of deferred financing costs	(2,400)	0	(6,934)
Payments on finance leases	(7,692)	(7,882)	(7,652)
Dividends paid to Class A common stock shareholders	(37,441)	(33,681)	(30,124)
Distributions to members	(15,604)	(13,290)	(16,644)
Repurchases of shares	(5,927)	(9,331)	(5,249)
Net cash (used in) provided by financing activities	(69,064)	(70,144)	103,275
Effect of exchange rate changes on cash and cash equivalents	1,449	(1,530)	503
Net increase (decrease) in cash, cash equivalents and restricted cash	151,739	209,051	(210,735)
Cash, cash equivalents and restricted cash
Beginning of period	342,843	133,792	344,527
End of period	$ 494,582	$ 342,843	$ 133,792